Consistent with this finding, another study that re-analyzed publicly available transcriptome data showed that ATG16L2 gene expression is downregulated whereas ULK1 gene expression is upregulated in blood samples of MS patients (20). Here, ULK1 is linked to myeloid sarcoma.